medicine

Big news today: 

GLP-1 shortage is over. This will have big implications for compounding pharmacies, patients but much much more 

Essentially, FDA declared not that Ozempic/Wegovy (semaglutide) shortage resolved, meaning compounded GLP-1s are no longer allowed, tanked HIMS stock. 

For perspective, ~25% of GLP-1s are compounded, serving millions of patients. And a big source of revenue for compounders that have shifted biz models, but even more so developed these into robust treatments (ex: B12/sema combo)

Compounders are now challenging in court to continue production, tirzepatide is already in court, semaglutide cases likely will join in. During this time, while the current lawsuit ongoing, FDA is maintaining its enforcement discretion. 

Now here is where this turns another corner:

spotlight

Hang out with us. Find the $SOCIAL frame in /socialtoken. docs.socialtoken.fyi

Claiming my @socialtoken airdrop and crediting @kevelyn with my social airdrop for being a good friend

Memes

Farcaster

🔔 BREAKING: Get ready to claim $FDOG

If you're already on Warpcast, you might be eligible for an airdrop. Don’t miss your slice of the action!

👉 Check it out here: https://farcasterdog.xyz 
https://www.youtube.com/watch?v=iiISaGiLePg

Anime

Reown (prev. WalletConnect Inc.)

A step-by-step tutorial on how to integrate AppKit with Next.js by our DevRel Lead @rohit7101

Head of DevRel @reown. I love photography, literature and motorcycles. I also love to travel

| bento.me/rohitramesh

A step-by-step tutorial on how to integrate AppKit with Next.js by our DevRel Lead @rohit7101 

 https://youtu.be/lxTGqXh7LiA

Shinyou

@ijojia